Isabelle

 

Soerjomataram

Isabelle Soerjomataram MD, PhD, MSc is a medical epidemiologist with a special interest in causes, and prevention of cancer. She took a position at IARC in 2011 where she is currently assessing international variation of the cancer burden and survival, and how health systems and policies can mitigate the rising burden of and inequality in cancer occurrence and outcome using mainly population-based databases. 

In addition to her research activities, she (co)coordinates several large projects funded by various institutions. Today she is leading an international benchmarking project to assess the determinants including health system of cancer survival and national and global projects to assess the contribution of various risk factors on the burden of cancer. 

Currently, she also co-leads the global consortium to assess the role of COVID-19 and health system resilience to mitigate impact on cancer services and cancer outcome across countries, and co-chair the Lancet Commission on Women and Cancer.